Showing results (1-10 of 647) with videos related to
Sort By:
Pageof 65
BMC Medical Genomics|July 1, 2015
Integrated approaches to miRNAs target definition: time-series analysis in an osteosarcoma differentiative modelA Grilli, M Sciandra, M Terracciano, et al.Current Cancer Drug Targets|December 23, 2009
Targeted therapies in bone sarcomasK Scotlandi, P Picci, H KovarAdvances in Experimental Medicine and Biology|December 14, 2006
Prognostic and therapeutic targets in the Ewing's family of tumors (PROTHETS)P Picci, K Scotlandi, M Serra, et al.Cytogenetic and Genome Research|December 28, 2007
Microdeletions in 9p21.3 induce false negative results in CDKN2A FISH analysis of Ewing sarcomaS Savola, F Nardi, K Scotlandi, et al.International Journal of Oncology|January 14, 2004
Effectiveness of Type I interferons in the treatment of multidrug resistant osteosarcoma cellsM C Manara, M Serra, S Benini, et al.Oncogene|May 2, 2007
CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activityK Scotlandi, M Zuntini, M C Manara, et al.Oncogene|May 7, 2013
CD99 suppresses osteosarcoma cell migration through inhibition of ROCK2 activityC Zucchini, M C Manara, R S Pinca, et al.Anticancer Research|May 1, 1992
Induction of HLA class II antigens in osteosarcoma cells by interferons and tumor necrosis factor alphaK Scotlandi, N Baldini, M Campanacci, et al.Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|November 24, 1999
P-glycoprotein expression in osteosarcoma: a basis for risk-adapted adjuvant chemotherapyN Baldini, K Scotlandi, M Serra, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 13, 2014
Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expressionM T Marino, A Grilli, C Baricordi, et al.Pageof 65